Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 22806451)

1.

Influence of age on false positive rates of urine-based tumor markers.

Horstmann M, Todenhöfer T, Hennenlotter J, Aufderklamm S, Mischinger J, Kuehs U, Gakis G, Stenzl A, Schwentner C.

World J Urol. 2013 Aug;31(4):935-40. doi: 10.1007/s00345-012-0906-1. Epub 2012 Jul 18.

PMID:
22806451
2.

A holistic comparative analysis of diagnostic tests for urothelial carcinoma: a study of Cxbladder Detect, UroVysion® FISH, NMP22® and cytology based on imputation of multiple datasets.

Breen V, Kasabov N, Kamat AM, Jacobson E, Suttie JM, O'Sullivan PJ, Kavalieris L, Darling DG.

BMC Med Res Methodol. 2015 May 12;15:45. doi: 10.1186/s12874-015-0036-8.

3.

Factors influencing false-positive results for nuclear matrix protein 22.

Behrens T, Stenzl A, Brüning T.

Eur Urol. 2014 Nov;66(5):970-2. doi: 10.1016/j.eururo.2014.06.014. Epub 2014 Jun 26. No abstract available.

PMID:
24976592
4.

Screening for bladder cancer with urinary tumor markers in chemical workers with exposure to aromatic amines.

Pesch B, Taeger D, Johnen G, Gawrych K, Bonberg N, Schwentner C, Wellhäusser H, Kluckert M, Leng G, Nasterlack M, Lotan Y, Stenzl A, Brüning T; UroScreen Study Group.

Int Arch Occup Environ Health. 2014;87(7):715-24. doi: 10.1007/s00420-013-0916-3. Epub 2013 Oct 16.

PMID:
24129706
5.

uCyt+/ImmunoCyt and cytology in the detection of urothelial carcinoma: an update on 7422 analyses.

Comploj E, Mian C, Ambrosini-Spaltro A, Dechet C, Palermo S, Trenti E, Lodde M, Horninger W, Pycha A.

Cancer Cytopathol. 2013 Jul;121(7):392-7. doi: 10.1002/cncy.21287. Epub 2013 Mar 12.

PMID:
23495066
6.

Comparison of fluorescence in situ hybridization, NMP22 bladderchek, and urinary liquid-based cytology in the detection of bladder urothelial carcinoma.

Li HX, Wang MR, Zhao H, Cao J, Li CL, Pan QJ.

Diagn Cytopathol. 2013 Oct;41(10):852-7. doi: 10.1002/dc.22969. Epub 2013 Feb 27.

PMID:
23444210
7.

Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma.

Todenhöfer T, Hennenlotter J, Esser M, Mohrhardt S, Tews V, Aufderklamm S, Gakis G, Kuehs U, Stenzl A, Schwentner C.

Cancer Cytopathol. 2013 May;121(5):252-60. doi: 10.1002/cncy.21247. Epub 2012 Nov 21.

PMID:
23172833
8.

The clinical usefulness of nuclear matrix protein-22 in patients with end-stage renal disease and microscopic hematuria.

Trojan B, Tang A, Chandrapal J, Filleur S, Nelius T.

Ren Fail. 2013;35(1):72-6. doi: 10.3109/0886022X.2012.741648. Epub 2012 Nov 14.

PMID:
23151051
9.

Individual risk assessment in bladder cancer patients based on a multi-marker panel.

Todenhöfer T, Hennenlotter J, Aufderklamm S, Kühs U, Gakis G, Germann M, Stenzl A, Schwentner C.

J Cancer Res Clin Oncol. 2013 Jan;139(1):49-56. doi: 10.1007/s00432-012-1297-9. Epub 2012 Aug 15.

PMID:
22893018
10.

Cytokeratin-20 immunocytochemistry in voided urine cytology and its comparison with nuclear matrix protein-22 and urine cytology in the detection of urothelial carcinoma.

Srivastava R, Arora VK, Aggarwal S, Bhatia A, Singh N, Agrawal V.

Diagn Cytopathol. 2012 Sep;40(9):755-9. doi: 10.1002/dc.21617. Epub 2011 Jan 6.

PMID:
22888081
11.

Reflex ImmunoCyt testing for the diagnosis of bladder cancer in patients with atypical urine cytology.

Odisho AY, Berry AB, Ahmad AE, Cooperberg MR, Carroll PR, Konety BR.

Eur Urol. 2013 May;63(5):936-40. doi: 10.1016/j.eururo.2012.04.019. Epub 2012 Apr 14.

12.

Detection of recurrent bladder cancer: NMP22 test or urine cytology?

Hosseini J, Golshan AR, Mazloomfard MM, Mehrsai AR, Zargar MA, Ayati M, Shakeri S, Jasemi M, Kabiri M.

Urol J. 2012 Winter;9(1):367-72.

13.

Influence of urinary tract instrumentation and inflammation on the performance of urine markers for the detection of bladder cancer.

Todenhöfer T, Hennenlotter J, Kühs U, Tews V, Gakis G, Aufderklamm S, Stenzl A, Schwentner C.

Urology. 2012 Mar;79(3):620-4. doi: 10.1016/j.urology.2011.10.067.

PMID:
22386412
14.

Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study.

Huber S, Schwentner C, Taeger D, Pesch B, Nasterlack M, Leng G, Mayer T, Gawrych K, Bonberg N, Pelster M, Johnen G, Bontrup H, Wellhäusser H, Bierfreund HG, Wiens C, Bayer C, Eberle F, Scheuermann B, Kluckert M, Feil G, Brüning T, Stenzl A; UroScreen Study Group.

BJU Int. 2012 Sep;110(5):699-708. doi: 10.1111/j.1464-410X.2011.10883.x. Epub 2012 Feb 7.

PMID:
22313585
16.

Impact of different grades of microscopic hematuria on the performance of urine-based markers for the detection of urothelial carcinoma.

Todenhöfer T, Hennenlotter J, Tews V, Gakis G, Aufderklamm S, Kuehs U, Stenzl A, Schwentner C.

Urol Oncol. 2013 Oct;31(7):1148-54. doi: 10.1016/j.urolonc.2011.10.011. Epub 2011 Nov 29.

PMID:
22130125
17.

Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis.

Shariat SF, Savage C, Chromecki TF, Sun M, Scherr DS, Lee RK, Lughezzani G, Remzi M, Marberger MJ, Karakiewicz PI, Vickers AJ.

Cancer. 2011 Jul 1;117(13):2892-7. doi: 10.1002/cncr.25903. Epub 2011 Jan 10.

18.

Role of NMP22 Bladder Check Test in early detection of bladder cancer with recurrence.

Kundal VK, Pandith AA, Hamid A, Shah A, Kundal R, Wani SM.

Asian Pac J Cancer Prev. 2010;11(5):1279-82.

19.

MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology.

Yamada Y, Enokida H, Kojima S, Kawakami K, Chiyomaru T, Tatarano S, Yoshino H, Kawahara K, Nishiyama K, Seki N, Nakagawa M.

Cancer Sci. 2011 Mar;102(3):522-9. doi: 10.1111/j.1349-7006.2010.01816.x. Epub 2010 Dec 19.

PMID:
21166959
20.

Performance of nuclear matrix protein 22 urine marker and voided urine cytology in the detection of urinary bladder tumors.

Smrkolj T, Mihelič M, Sedlar A, Sterle I, Osredkar J, Sedmak B.

Clin Chem Lab Med. 2011 Feb;49(2):311-6. doi: 10.1515/CCLM.2011.038. Epub 2010 Dec 1.

PMID:
21118051
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk